immunosuppressive therapy
AGA Issues Updated Guideline on Preventing HBV Reactivation
The AGA has issued an updated clinical practice guideline on prevention and management of HBV reactivation in ...
APRIL 14, 2025
Solving the Nutrition–Drug Interactions Puzzle in Transplant Patients
Many of the immunosuppressive medications used for solid-organ transplants have known interactions with nutrition ...
SEPTEMBER 10, 2024
Study Looks at Infection Risk in Older IBD Patients on Immunosuppressive Therapies
Older adults represent a growing segment of patients with IBD, and several unique factors should be considered when ...
AUGUST 30, 2024
Review Points to Safety of FMT for CDI in Immunocompromised Patients
A study of immunocompromised patients who underwent fecal microbiota transplantation for Clostridioides difficile ...
JANUARY 19, 2022
Recommended Pneumococcal Vaccine Omitted for Many GI Patients at Risk
Gastroenterologists provide care to one-fourth of patients at high risk for pneumococcal disease because they are ...
NOVEMBER 15, 2019
Immune-Blocking Approach Safe for IBD in Peds
Immunosuppressive therapy is generally safe for pediatric-onset inflammatory bowel disease (IBD), according to ...
JUNE 25, 2016
